RQM+ (Linden Capital) Acquires Jordi Labs

September 7, 2022

RQM+, a MedTech CRO and portfolio company of Linden Capital Partners, has acquired Jordi Labs, a specialist analytical chemistry and laboratory testing provider serving medical device and pharmaceutical customers. The deal strengthens RQM+'s lab services and extractables & leachables capabilities to support regulatory submissions and product development; Harris Williams advised Jordi Labs on the transaction.

Buyers
RQM+, Linden Capital Partners
Targets
Jordi Labs
Sellers
Jordi family
Platforms
RQM+
Location
Massachusetts, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.